second annual pathology educational...

Second Annual Pathology

Educational Symposium

September 29 - October 2, 2014

Turner Auditorium 720 Rutland Avenue

Baltimore, MD 21205

Sponsored by the Department of Pathology

2

Description: This Continuing Education event is intended for all Johns Hopkins Medicine Department of Pathology staff.

Cost: Free to Pathology employees.

Preregistration is encouraged. See your Supervisor to preregister. JHM ID is required for electronic attendance tracking.

Registration: Lower Turner Concourse

Register in person only once on the first day of attendance. Breaks: Light refreshments available between sessions in the Lower Turner Concourse. Lunch: Will be provided for days attendee is preregistered. Pick-up is in the West Room. Monday, September 29 12:15-12:50p Tuesday, September 30 12:00-12:45p Wednesday, October 1 12:00-12:45p Attendance Documentation & Certificate:

1. Swipe ID badge or sign in for all sessions attending 2. Document Session Code on Attendance Documentation

form 3. Turn in completed Attendance Documentation form at

registration desk or email to Symposium Committee. Both sign-in (or swipe-in) and Attendance Documentation form are required to receive your PACE® certificate.

4. Certificate and Evaluations will be emailed to attendee after the Symposium.

Johns Hopkins Medicine is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

3

Monday, September 29, 2014

9a-3:30p: Registration (Turner Concourse) 10:00a-11:00a Room: Tilghman Auditorium

The Journey of a Breast Biopsy: Part 1 Course # 612-108-14 / 1.0 credit hours

Leigh Plomchock, MS, PA(ASCP)CM

Lead Pathologists’ Assistant, Surgical Pathology Laboratory, The Johns Hopkins Hospital

Carolyn Gallagher, HT(ASCP) Histopath Tech II, Surgical Pathology Laboratory, The Johns Hopkins Hospital

Nichelle Gray, BS Clinical Laboratory Coordinator, Immunopathology Laboratory, The Johns Hopkins University School of Medicine

Charlotte Randall-Ramos Specimen Accessioning Coordinator, Surgical Pathology Laboratory, The Johns Hopkins Hospital United States Army, Sgt A.S

Patricia Marsh, BS Consult Coordinator, Surgical Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Histology/Surgical Pathology Target Audience: All are welcome Description: How does a pathologist make a diagnosis? What areas assist and work in unison to achieve that quick turnaround time to give an accurate result to the patient? Accessioners, pathologist assistants, histotechnologists, the Immunohistochemistry Lab, the Consult Office, the Cytogenetics Lab, and all our support staff understand that the importance of close communication cannot be overemphasized in patient care. Smooth workflow with the concentration on accuracy and quality of the specimen will achieve the correct diagnosis from our pathologists for our patients. Objectives: At the completion of the presentation, the audience will be able to:

Recognize all the areas involved in obtaining a diagnosis of breast cancer

Identify key processing steps of a breast biopsy

4

Monday, September 29, 2014 10:00a-11:00a Room: TBD

Laboratory Diagnosis of Celiac Disease and Gluten-

Related Disorders Course # 612-141-14 / 1.0 credit hours

Daniela Cihakova, MD, PhD, D(ABMLI)

Assistant Professor of Pathology Director, Immune Disorders Laboratory, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Immunology Target Audience: All are welcome Description: Celiac disease (CD) is an autoimmune-mediated inflammation of the small intestine, strongly dependent on HLA-DQ2 and HLA-DQ8 haplotypes characterized by intolerance of dietary gluten present in wheat, rye, and barley. The diagnostic criteria for celiac disease (CD) have remained unchanged for more than 20 years. However, in 2013 the American College of Gastroenterology and independently the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) both published new guidelines for the diagnosis of CD. We will summarize the main changes with the emphasis on laboratory testing in diagnosis of CD. Besides CD, there are other gluten-related disorders, wheat allergy and gluten sensitivity. There is a great interest in gluten sensitivity and its relation to other disorders and overall health. We will discuss which laboratory methods are currently used for diagnosis of gluten sensitivity. Objectives: At the completion of the presentation, the audience will be able to:

Describe new evidence-based guidance for diagnosis of celiac disease

Explain the use of different laboratory tests in diagnosis of celiac disease

Describe the clinical presentation and laboratory findings of other gluten-related disorders

5


11:15a-12:15a Room: Tilghman Auditorium

The Journey of a Breast Biopsy: Part 2 - “Pathology

of the Breast” Course # 612-109-14 / 1.0 credit hours

Pedram Argani, MD Professor of Pathology, Surgical Pathology Laboratory, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Histology/Surgical Pathology Target Audience: All are welcome Description: Breast cancer is the No. 2 cause of cancer in women in the USA. One out of every nine American women will develop breast cancer. This presentation will focus on normal breast tissue, common benign causes of a breast mass or microcalcifications, ductal carcinoma in situ, and invasive ductal carcinoma. Sample cases will also be discussed. Objectives: At the completion of the presentation, the audience will be able to:

Identify the anatomy of the breast

Explain the pathology of the breast

6


11:15a-12:15p: Room: Turner Auditorium

Pathology at Johns Hopkins: A History

Course # 612-101-14 /1.0 credit hour

Edward F. McCarthy, MD Professor of Pathology and Orthopedic Surgery, The Johns Hopkins University School of Medicine

Level of Instructions: Basic Category: General Target Audience: All are welcome Description: Have you ever wondered about the history of Pathology at Johns Hopkins? Join us for the kick-off of the Second Annual Pathology Educational Symposium with a history lesson about the early years of Pathology at Johns Hopkins Medicine. Objectives: At the completion of the presentation, the audience will be able to:

Recall the history of Johns Hopkins Pathology

Identify the various Chairmen in the Department of Pathology

Discuss how the Department of Pathology was founded

7


1:00-2:00p: Room: TBD

Blood Group Family Feud Course # 612-102-14 / 1.0 credit hours

Zachary Bergner, MT(ASCP) Instrument Specialist, Transfusion Medicine, The Johns Hopkins Hospital

Lorraine N. Blagg, MA, MLS(ASCP)CMSBB Education & Development Coordinator, Transfusion Medicine, The Johns Hopkins Hospital

Level of Instruction: Intermediate Category: Immunohematology/Blood Bank Target Audience: Technologists, leads, supervisors, managers, and educators Description: It’s time to play the Feud! This will be an interactive game based on the TV show, Family Feud. Two Blood Group families (Kell and Dombrock) will be pitted against one another to name the most popular responses to survey-type questions about Blood Groups. Our families will be selected from the audience. Objectives: At the completion of the presentation, the audience will be able to:

Participate in an interactive way to review immunohematology facts

Identify antigens and antibodies based on their serologic characteristics

8


1:00-2:00p: Room: TBD

HPV-Related Head and Neck Squamous Cell

Carcinoma Course # 612-127-14 / 1.0 credit hours

Zahra Maleki, MD Assistant Professor of Pathology, Division of Cytopathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Cytopathology/Molecular Target Audience: All are welcome Description: This presentation reviews HPV-related head and neck squamous cell carcinoma, including patient demographics, risk factors, anatomic sites, and morphologic findings in cytology and histology specimens. It reviews the role of fine needle aspiration in diagnosis of HPV-related squamous cell carcinoma. It describes the roles of cytotechnologists and cytopathologists in immediate interpretation of the aspirated samples for specimen adequacy. It reviews the molecular studies performed for diagnostic, therapeutic, and prognostic purposes. Finally, it reviews the similarities and differences between HPV-related and non-HPV-related head and neck squamous cell carcinomas. Objectives: At the completion of the presentation, the audience will be able to:

Describe the role of fine needle aspiration in diagnosis of HPV-related head and neck squamous cell carcinoma

Describe the roles of the cytotechnologists and cytopathologists in immediate interpretation of the samples for specimen adequacy

Describe patient demographics, risk factors, anatomic sites, histology and cytology findings, and molecular studies

Describe the similarities and differences between HPV-related and non-HPV-related head and neck squamous cell carcinomas

9


2:15-3:15p: Room: TBD

Contributions of the Laboratory to the Diagnosis of

Human Allergic Disease

Course # 612-120-14 / 1.0 credit hours

Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Intermediate Category: Immunology Target Audience: All are welcome

Description: Diagnosis of human allergic disease begins with a careful clinical history. Once there is a suspicion of an allergic process, IgE antibody is detected to confirm sensitization and provide guidance on a management strategy. The clinical laboratory continues to play a vital role in facilitating the diagnosis of allergic disease through the quantification of allergen-specific IgE antibody in serum. This overview will discuss the pathophysiology and clinical manifestations of allergic reactions and discuss the serological assays used to quantify IgE antibody to approximately 200 allergen specificities. Component-resolved diagnosis and multiplex technology will be discussed. Objectives: At the completion of the presentation, the audience will be able to:

Identify the pathophysiology of the allergic reaction in humans

Discuss the laboratory methods used to assess a patient for allergic sensitization

Explain the importance of component-resolved diagnosis using individual native and recombinant allergens

Identify how laboratory methods interface with in vivo provocation testing methods in the diagnostic algorithm

10


2:15-3:15p: Room: TBD

Tissue Donation for Transplantation: The People, the

Process and the Success of Allograft Transplants


Rick Kolovich, RN, CPTC, CCTC, CTBS Clinical Manager, Donor Services Living Legacy Foundation

Steven Bell Area Business Manager, Musculoskeletal Transplant Foundation (MTF)

Elizabeth McNamara, RN, MSN Senior Regional Director, Musculoskeletal Transplant Foundation

Level of Instruction: Basic Category: General/ Blood Bank Target Audience: All are welcome

Description: The gift of musculoskeletal tissue (bone) donation after death

has a profound effect annually on thousands of recipients. The gift of bone donation provides individuals with a renewed ability to walk, throw a ball, pick up their grandchildren, return to work and be pain-free while in activity. The gift additionally assists the donor family/significant others as they seek to find solace and a positive outcome from the loss of their loved one. Musculoskeletal donation is a win-win for so many. How can you help? This presentation will discuss the referral/recovery process and bone utilization at Johns Hopkins Medicine. Critical to the process is communication to the Living Legacy Foundation of the potential donor and the hospital course. On the recipient side, the knowledge of the utilization of bone in a variety of forms and procedures and the communication to the allograft recipient of the MTF Linking Lives program is key.

Objectives: At the completion of the presentation, the audience will be able to:

Describe the Living Legacy Foundation’s (LLF) tissue donation process, from referral to recovery

Describe LLF’s primary and secondary screening process of potential donors and the impact on Johns Hopkins Medicine

Describe the significance of allograft utilization at Johns Hopkins Medicine and the positive impact on the recipient lives

11


3:30-4:30p: Room: TBD

Stem Cell Products: What’s in The Bag?


Janice Davis-Sproul, MAS, MT(ASCP)SBB Manager, Cell Therapy Laboratory, The Johns Hopkins University

Angela Ondo, MT(ASCP) BMT/CTL Quality Assurance Manager, Cell Therapy Laboratory, The Johns Hopkins Hospital

Level of Instruction: Basic Category: Cellular Therapy/Blood Bank/Hematology Target Audience: All are welcome

Description: This presentation will discuss hematopoietic stem cell sources, cellular therapy product processing and testing, and the role of quality in the Cell Therapy Laboratory. Objectives: At the completion of the presentation, the audience will be able to:

Identify sources of stem cells

Describe product processing based on the donor and recipient’s ABO type

Discuss product testing (sterility and flow cytometric) and acceptable results

Describe future roles for cell-based therapies in cancer treatments

12

Tuesday, September 30, 2014 8a-3:30p: Registration (Turner Concourse)

8:30a-10:45a Room: Tilghman Auditorium

The Art of Quality Control, Selected Topics Course # 612-118-14 / 2.0 credit hours

Michael Toyoshima, MT(ASCP)SC, CLS Technical Support Advisor, Bio-Rad Laboratories, Irvine, California

Level of Instruction: Intermediate Category: Clinical Chemistry/Hematology/Quality Assurance Target Audience: Technologists, leads, supervisors, managers, and those who use lab results Description: Inappropriate quality control wastes time and resources and may lead to the release of incorrect patient results. Attend this workshop to improve the quality control of your laboratory testing. Through lecture and case studies you will explore the fundamentals and real life applications of quality control, learn what to do about unexpected QC values, and add problem-resolution schemes to your troubleshooting skills. Objectives: At the completion of the presentation, the audience will be able to:

Explain the conditions and steps involved in obtaining a valid QC image

Perform troubleshooting of specific laboratory problems by reviewing reports and applying appropriate QC principles

13

Tuesday, September 30, 2014

8:30a-9:30a Room: TBD

The Next Generation of Cancer Diagnostics: Clinical

Proteomics? Course # 612-114-14 / 1.0 credit hours

Daniel W. Chan, PhD, DABCC, FACB Professor of Pathology, Oncology, Radiology, and Urology Director, Clinical Chemistry Division, and the Center for Biomarker Discovery and Translation, The Johns Hopkins Medical Institutions

Level of Instruction: Basic Category: Clinical Chemistry/Molecular/Research Target Audience: All are welcome Description: The future of tumor markers will likely come from the discoveries of proteomic biomarkers. In this presentation, the research conducted at the Center for Biomarker Discovery and Translation will be described. In addition, pictures will be shown of the advances in the world of proteomic technologies and how they were used to translate ovarian and prostate cancer biomarkers into clinical diagnostics for patient care. Objectives: At the completion of the presentation, the audience will be able to:

Describe tumor markers for clinical application

Describe proteomics technologies

Review the process of biomarker discovery

Explain the process of biomarker translation

14



Emerging and Reemerging Viral Infections Course # 612-129-14 / 1.0 credit hours

Nicole Kwiatkowski, MLS(ASCP)CM

Laboratory Supervisor, Microbiology, The Johns Hopkins Hospital

Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome

Description: A review of the ecology, epidemiology, clinical manifestations and diagnostics testing of recently emerging and re-emerging viral pathogens. Objectives: At the completion of the presentation, the audience will be able to:

Describe general viral infective cycles

Categorize viruses in the appropriate genetic class

Describe clinical manifestations, ecology, and epidemiology of the covered emerging viral pathogens

Explain virus-vector-host interactions

15



JHH Response to Shooter Event: Options for

Employees Course # 612-138-14 / 1.0 credit hours

Howard Gwon, MS, CHEC Senior Director, Office of Emergency Management, Johns Hopkins Medicine

Level of Instruction: Basic Category: General/Safety (Emergency Management) Target Audience: All are welcome

Description: Hospitals may be faced with incidents of workplace violence with little or no warning. The Johns Hopkins Medicine Senior Director of Emergency Management will present options for employees on how to respond to an active shooter while on duty. He will also review the Hospital's response procedures in conjunction with these responsibilities. Objectives: At the completion of the presentation, the audience will be able to:

Discuss impact of active shooter incidents in hospitals and healthcare settings

Describe how to respond to an active shooter

Describe how to better protect oneself and others in using the options “run, hide, fight”

16



TB Testing in International Laboratories -- Changes

and Challenges Course # 612-117-14 / 1.0 credit hours

Peggy Coulter, MDE, MT(HEW) Senior International Laboratory QA/QC Coordinator, Patient Safety Monitoring in International Laboratories (SMILE), The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Microbiology/Quality Assurance Target Audience: All are welcome Description: This presentation will show how Tuberculosis (TB) laboratories have changed over the last 10 years in areas where TB prevalence is high. It will also cover some of the challenges that TB laboratories encounter and the measures taken to overcome them. During the presentation, the impact of improvement in biosafety practices, advances in technology, QA/QC, as well as the importance of attitudes will be covered. Objectives: At the completion of the presentation, the audience will be able to:

Describe the significance of Tuberculosis infection worldwide

Identify changes in policy and standards relating to TB laboratories

Explain how biosafety has changed in laboratories in developing countries

Discuss quality indicators and new tuberculosis diagnostic methods

17

Tuesday, September 30, 2014 11:00a-12:00p Room: TBD

Weird Micro, Part Deux: More Interesting Cases

from the Lab Course # 612-103-14 / 1.0 credit hours

Paula Mister, MS, MT(ASCP)SM Educational & Development Coordinator, Clinical Microbiology, The Johns Hopkins Hospital

Level of Instruction: Intermediate Category: Microbiology Target Audience: Technologists, leads, supervisors, managers, physicians Description: Back by popular demand!! Case presentations of unusual pathogenic microorganisms, or pathogens from unexpected body sources, from specimens received in the Johns Hopkins Clinical Microbiology Laboratory. This will be an interactive session, similar to last year, in which clues are given to assist participants in making the correct diagnosis. There will be a brief discussion of methods both new and old, to assist technologists in recognition and identification of these pathogens. Objectives: At the completion of the presentation, the audience will be able to:

Integrate information from patient history, symptoms, lab results, and additional clues to postulate microbiologic pathogens from cases presented

Develop an increased awareness of potentially unusual pathogens and pathogens from unusual sources in the clinical laboratory

Describe laboratory methods that can detect these pathogens in an accurate and timely manner

18

Tuesday, September 30, 2014 11:00a-12:00p Room: TBD

Preventing Disruptive Behavior from Escalating at

Work Course # 612-125-14 / 1.0 credit hours

Errin Britt, JD, PHR Program Manager, Johns Hopkins Workplace Violence Assessment

Level of Instruction: Basic Category: Administrative/HR/Safety Target Audience: All are welcome Description: This module is designed to help employees better understand what disruptive behaviors look like and how to respond when there are concerns. Objectives: At the completion of the presentation, the audience will be able to:

Identify basic facts about disruptive behaviors at work

Review the Johns Hopkins Continuum of Disruptive Behaviors at work

Review how to identify behaviors of concern

Locate resources to help

19


11:00a-12:00p Room: TBD

Not Your Typical Blood Bank Case Studies Course # 612-105-14 / 1.0 credit hours

Lorraine N. Blagg, MA, MLS(ASCP)CMSBB Education & Development Coordinator, Transfusion Medicine, The Johns Hopkins Hospital

Level of Instruction: Intermediate Category: Immunohematology/Blood Bank Target Audience: Technologists, leads, supervisors, managers, educators Description: Not all decision-making and problem-solving in the blood bank revolve around antibody identification. This presentation will utilize case studies and your smartphone to answer questions that encompass analysis of serologic results, clinical data, patient history, and technology to resolve problems faced in the blood bank. Objectives: At the completion of the presentation, the audience will be able to:

Analyze serology and patient medical history to resolve unexpected results

Evaluate special methods or technology to address problems presented in the blood bank

Recommend transfusion management based on clinical and serological information

Utilize your smartphone and Poll Everywhere app to answer questions for each case presented (http://www.PollEv.com/bloodbankcases)

http://www.pollev.com/bloodbankcases

20


1:00p-3:15p (15 minute break) Room: TBD

The Clinical Laboratory in Sub-Saharan Africa Course # 612-110-14 / 2.0 credit hours

Timothy Amukele, MD, PhD Assistant Professor of Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Quality Assurance/ Regulatory/ Immunology Target Audience: All are welcome Description: Many people are interested in the state of laboratories in poor countries, but aside from occasional reports of missionaries helping individual hospitals, there isn’t much known. This lecture will summarize much of the research in laboratories in Sub-Saharan Africa, their number and quality, as well as test use and test costs. The conversation will be framed in terms of which interventions serve to improve quality in settings without regulatory oversight. Objectives: At the completion of the presentation, the audience will be able to:

List the number and location of accredited labs in Sub-Saharan Africa (SSA)

Describe the quality of the “best” labs in SSA compared to labs in the West

Identify the factor most strongly associated with high quality of “average” labs

Describe laboratory test use and laboratory test costs in Sub-Saharan Africa

21


Time: 1:00p-2:00p Room: TBD

Legal Highs: A Packet and a Patient. What can the

Clinical Laboratory Do? Course # 612-122-14 / 1.0 credit hours

David A. Sartori, PhD Clinical Chemistry Fellow, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Clinical Chemistry Target Audience: All are welcome Description: Bath salts (synthetic cathinones) represent a new and potentially dangerous class of drugs of abuse, involving intoxication that can present as a sympathomimetic toxidrome. Duration and clinical presentation can be complicated by co-ingestion of depressive agents. Clinical testing for these compounds is very difficult and limited to specific reference labs at the moment. A review of the literature and discussion of a clinical case will be presented. Objectives: At the completion of the presentation, the audience will be able to:

Recognize the structural diversity of synthetic cathinones

Discuss of the limitations of clinical testing and potential testing for the future

Identify the diverse clinical presentation and range of effects that users have

22



Of Plague and Pestilence: A Disease of the Past? Course # 612-130-14 / 1.0 credit hours

Nicholas Boire, ScM Research Technologist, Department of Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Microbiology Target Audience: All are welcome Description: Plague is one of the most well-known and important diseases in human history. While most people know the “Black Death” that plagued Europe throughout the Middle Ages, fewer know of plague’s existence and relevance today. Despite its apparent absence in our daily life, plague is an important re-emerging infectious disease. This discussion will highlight the history of plague, including its use in bio-warfare; its microbiology (diagnostics, pathogenicity, and treatment); and finally, factors which may contribute to plague possibly becoming what it once was—a pandemic killer. Objectives: At the completion of the presentation, the audience will be able to:

Discuss factors responsible for plague outbreaks

Recall a thorough historical account of plague

Explain clinical and laboratory aspects of plague, including identification, pathology, and treatment

23


Time: 2:15p-3:15p Room: Tilghman Auditorium

The Microbiology of Food: James Beard Meets

Typhoid Mary Course # 612-136-14 / 1.0 credit hours

Brandon C. Ellis, MLS(ASCP)CM Supervisor, Microbiology, The Johns Hopkins Hospital

Level of Instruction: Basic Category: Microbiology Target Audience: All are welcome

Description: Microbiology plays an important role in the culinary world, from the mushrooms we eat to the bacteria and fungi used to make cheese, bread, wine, and beer. While these microbes play an integral part in making some of the best food and drinks in the world, others can cause serious foodborne illnesses and death. This presentation includes an introduction to some of the microbiological processes used to produce food, common foodborne illnesses, and food safety. Objectives: At the completion of the presentation, the audience will be able to:

Describe microbiological techniques and processes used to produce cheese, beer, and other food and drinks

Discuss common foodborne illnesses and their impact on the food industry and society

Utilize good food safety practices and culinary tips

24



Diagnosis & Treatment of Thrombotic

Thrombocytopenic Purpura Course # 612-137-14 / 1.0 credit hours

Jennifer Bynum, MD Resident Physician, Department of Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Hematology/Blood Bank Target Audience: All are welcome Description: Thrombotic Thrombocytopenic Purpura (TTP) is a rapid onset and potentially fatal disorder in which both clotting and bleeding occur. Unlike most bleeding in thrombocytopenic patients, platelet transfusions are contraindicated. We will discuss causes, signs and symptoms, laboratory testing, and treatment options. Objectives: At the completion of the presentation, the audience will be able to:

Describe the pathophysiology of TTP

Identify laboratory tests that aid in diagnosis and treatment monitoring of TTP

Recommend treatment options

Discuss the use of different replacement fluids in plasma exchange

25


Time: 3:30p-4:30p Room: Tilghman Auditorium

Safety of Today’s Plasma-Derived Products Course # 612-139-14 / 1.0 credit hours

Paula Ulsh, RN, BSN Senior Medical Science Liaison, Hemostasis, Kedrion Biopharma Inc.

Level of Instruction: Basic Category: Blood Bank/Hematology Target Audience: All are welcome

Description: Presentation on the safety of today's human source plasma products including understanding the past history and the industry response for improved an safety profile, Plasma Protein Therapeutic Association (PPTA) Industry Standards, and the Seven Safety Steps built into the manufacturing process from donor plasma collection to final product. Objectives: At the completion of the presentation, the audience will be able to:

Recall the past history of human source plasma products, risk identification, and the industry’s response for an improved safety profile

Identify the Plasma Protein Therapeutic Association (PPTA) Industry Guidelines

Identify the Seven Safety Steps built into the manufacturing process from donor plasma collection to final human source product and pharmacovigilence monitoring

26

Wednesday, October 1, 2014

8a-3:30p: Registration (Turner Concourse) 8:30a-9:30a Room: Tilghman Auditorium

Hematology Hodgepodge Course # 612-119-14 / 1.0 credit hours

Michael Tushek, MT(ASCP)SH Clinical Laboratory Scientist III, Howard County General Hospital

Level of Instruction: Intermediate Category: Hematology Target Audience: Technologists, leads, supervisors, managers, educators Description: There will be six to eight case studies presented from various areas of hematology to include coagulation, parasitology, hemoglobinopathies, and leukemias. Objectives: At the completion of the presentation, the audience will be able to:

Develop the ability to use multiple disciplines to come up with a diagnosis in an unusual or rare disease state

Interpret laboratory results and associate them with a differential diagnosis

27


8:30a-9:30a Room: Miller Research Building (MRB) G01

Best Practices in Phlebotomy Course # 612-142-14 / 1.0 credit hours

Charles Andrews Jr., PBT (ASCP) PACE Business Analyst, Johns Hopkins Healthcare

Level of Instruction: Basic Category: Phlebotomy Target Audience: Phlebotomists, technologists, leads, supervisors, managers, nurses, physicians

Description: Phlebotomists are the face of the clinical laboratory because they are the primary interaction patients have with their laboratory results. Phlebotomy skill is not only drawing blood for testing, but involves interacting and answering patient questions, and ensuring that the right specimen from the right patient is drawn at the right time. Objectives: At the completion of the presentation, the audience will be able to:

Identify the role of the phlebotomist in the process of diagnosis and/or treating patients

Explain the importance of proper patient identification

Prepare to respond to patient questions during phlebotomy

28


8:30a-10:45a Room: Turner Auditorium

The Art of Quality Control, Selected Topics (Repeat presentation)


Michael Toyoshima, MT(ASCP)SC, CLS Technical Support Advisor, Bio-Rad Laboratories, Irvine, California

Level of Instruction: Intermediate Category: Clinical Chemistry/Hematology/Quality Assurance Target Audience: Technologists, leads, supervisors, managers, those who use lab results Description: Inappropriate quality control wastes time and resources and may lead to the release of incorrect patient results. Attend this workshop to improve the quality control of your laboratory testing. Through lecture and case studies you will explore the fundamentals and real life applications of quality control, learn what to do about unexpected QC values, and add problem-resolution schemes to your troubleshooting skills. Objectives: At the completion of the presentation, the audience will be able to:

Explain the conditions and steps involved to obtain a valid QC image

Perform troubleshooting of specific laboratory problems by reviewing reports and applying appropriate QC principles

29

Wednesday, October 1, 2014 9:45a-10:45a Room: Tilghman Auditorium

Meeting Meaningful Use Stage 2: A Focus from the

Laboratory Course # 612-107-14 / 1.0 credit hours

P. Michael Huppenthal, MBA, MT(ASCP) Pathology Project Administrator, The Johns Hopkins Hospital

Level of Instruction: Basic Category: Computer/IT Target Audience: All are welcome Description: A new federal government incentive program has been developed that rewards healthcare providers and organizations who invest in Electronic Health Records (EHR) technology. The incentives are based on how the provider or organization is “meaningfully using the EHR.” This presentation will focus on describing the objectives of meeting meaningful use and how workflow at the lab bench impacts key measures. Objectives: At the completion of the presentation, the audience will be able to:

Explain the basics of Meaningful Use

Describe Core, Menu, and Quality Measures

Review lab-specific measures and identify how we meet the objectives

Report on how The Johns Hopkins Hospital is doing since the July 1 attestation

30


9:45a-10:45a Room: Miller Research Building (MRB) G01

Role of Fine Needle Aspiration in Head and Neck

Mass Lesions Course # 612-126-14 / 1.0 credit hours

Zahra Maleki, MD Assistant Professor of Pathology, Cytopathology Division, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Cytopathology Target Audience: All are welcome Description: This presentation reviews the fine needle aspiration procedure and its advantage in head and neck lesions. It describes the roles of cytotechnologists and cytopathologists in immediate interpretation of specimens and specimen triage. It reviews the main categories of head and neck lesions including congenital, infectious and neoplastic with a review of thyroid, salivary gland, lymph node, and a few miscellaneous lesions. Finally, it reviews the role of cytology in treatment and prognosis of malignant neoplasms in head and neck lesions with emphasis on ancillary studies, e.g., immunohistochemistry and molecular studies. Objectives: At the completion of the presentation, the audience will be able to:

Describe the fine needle aspiration procedure and its advantage

Describe the roles of cytotechnologists and cytopathologists in immediate interpretation of specimens of specimen triage

Recognize main categories of head and neck lesions including congenital, infectious, and neoplastic, with examples of multiple organs

Describe the role of cytology in diagnosis, treatment, and prognosis of neoplastic lesions using ancillary studies such as immunohistochemistry and molecular studies

31


11:00a-12:00p Room: TBD

Know Your Team Course # 612-140-14 / 1.0 credit hours

Anita Morris-Hopkins Laboratory Support Services Supervisor, Surgical Pathology Lab, The Johns Hopkins Hospital

Level of Instruction: Basic Category: General Target Audience: All are welcome Description: This presentation is designed to help supervisors better know the people they are leading. Attendees will learn how to build relationships that can make a difference between an employee staying or leaving. In this discussion attendees will learn how to create an environment of trust in which the team feels motivated to meet goals and contribute to the success of the department. Your team will recognize your genuine efforts to get to know their perspectives and contributions. Objectives: At the completion of the presentation, the audience will be able to:

Explain how to improve your work environment

Identify two helpful ways to better know your team

Formulate a way to increase your accuracy of perception, to become a better observer

Demonstrate how to work with people who have different styles

32


11:00a-12:00p Room: TBD

Common Brain and Eye Specimens and Disease Course # 612-115-14 / 1.0 credit hours

Charles G. Eberhart, MD, PhD Professor of Pathology, Director of Neuropathology and Ophthalmic Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Histology/Surgical Pathology Target Audience: All are welcome Description: Overview of the specimens which commonly come from ophthalmologists and neurosurgeons, including discussion of how to process them and common diagnoses. Objectives: At the completion of the presentation, the audience will be able to:

Discuss issues which can arise when processing ophthalmic specimens

Discuss issues which can arise when processing neurosurgical specimens

33


11:00a-12:00p Room: TBD

Antimicrobial Susceptibility Testing: What is the True

Clinical Value? Course # 612-131-14 / 1.0 credit hours

Stefan Riedel, MD, PhD, D(ABMM) Director, Clinical Pathology Laboratory, The Johns Hopkins Bayview Medical Center

Level of Instruction: Intermediate Category: Microbiology Target Audience: Technologists, leads, supervisors, managers, nurses, physicians, physician assistants Description: This presentation will discuss various methods used for antimicrobial susceptibility testing and the interpretive guidelines used when applying these methods. The final discussion will include aspects of clinical utility and impact on patient care. Objectives: At the completion of the presentation, the audience will be able to:

Describe the various methods used for antimicrobial susceptibility testing (AST)

Describe the principles of interpretive guidelines for AST

Describe the limitations of AST

Describe the clinical utility and implications for patient care

34


1:00p-2:00p Room: Tilghman Auditorium

Next Generation Sequencing Course # 612-113-14 / 1.0 credit hours

James R. Eshleman, MD, PhD Professor of Pathology, Department of Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Intermediate Category: Molecular Target Audience: All are welcome Description: Next Generation DNA Sequencing (NGS) has revolutionized biomedical discovery. For example, in the next few years all gene mutations for all the cancers will be known. The impact of NGS on clinical molecular diagnostics will explode in the next decade. Objectives: At the completion of the presentation, the audience will be able to:

Explain the basic methods of Next Generation Sequencing

Appreciate the impact Next Generation Sequencing will have on clinical testing

35


1:00p-2:00p Room: TBD

Inspection Readiness


Barbara Parsons, MA, MT(ASCP) Assistant Director, Quality Management, Pathology Department, Johns Hopkins Medicine

Deborah Williams, MT(ASCP) Laboratory Quality Assurance Coordinator, Suburban Hospital

Jeanne Mumford, MT(ASCP) Laboratory Quality Assurance Specialist, Johns Hopkins Community Physicians

Level of Instruction: Basic Category: Quality Assurance Target Audience: All are welcome Description: Clinical laboratories must submit to an unannounced inspection

by federal or designated accreditation body inspectors at least every two years. These inspections are complete and systematic evaluations to determine a laboratory's ability to provide accurate and reliable results. Laboratories must be "inspection ready" at all times to conform with regulatory requirements, as well as to continually ensure quality and safe patient care. This session will provide participants with methods and tools to maintain ongoing readiness in various types of laboratories. How to address laboratory staff engagement in the readiness process will be included.

Objectives: At the completion of the presentation, the audience will be able to:

Describe how ongoing inspection readiness will help you prepare for an unannounced on-site inspection

Compare what inspection readiness means to different types of laboratories

Explain the importance of laboratory staff participation in the inspection readiness process

Describe how inspection ready methods and tools will help improve laboratory quality and promote continuous compliance with regulatory requirements

36


1:00p-2:00p Room: Miller Research Building (MRB) G01

Innovation: Thinking Outside the Box (Limit 40 attendees) Course # 612-123-14 / 1.0 credit hours

Megeen Thomas Administrative Coordinator, Department of Learning & Development, Talent Management and Organization Development, The Johns Hopkins University

Julia Jorczak Talent Management Consultant, Talent Management and Organization Development, The Johns Hopkins University

Level of Instruction: Basic Category: General Target Audience: Limited to Pathology staff only Description: No doubt about it -- we live and work in an environment that is constantly changing. As a result, we are called upon to become more flexible, creative, adaptable, and resilient than ever before. During this session, you will learn to amplify your innate ability to be creative and innovative, which will help you manage both your personal and professional challenges. Objectives: At the completion of the presentation, the audience will be able to:

Define what it means to be innovative

Identify characteristics of innovative individuals and teams

Identify and address your personal blocks to being innovative

Explore various “creativity boosters” to help you and your team apply innovative approaches and solutions

37


2:15p-3:15p Room: Turner Auditorium

Social Media Liability for Health Care Practitioners

and Staff Course # 612-112-14 / 1.0 credit hours

Jeffrey Natterman, RRT, MA, JD Risk Manager, The Johns Hopkins Hospital Associate Senior Counsel, Johns Hopkins Health System

Level of Instruction: Basic Category: Legal/Safety Target Audience: All are welcome Description: With the universality of communication technology and social media, health care workers are at increased risk of exposure to civil, criminal, and administrative liability for failure to follow regulations and specific duties. The cost to staff can be in the form of monetary damages, criminal sanctions, and licensure-related penalties. The law is complex, but over the years has become clearer with each subsequent generation of communication technology and case law. Objectives: At the completion of the presentation, the audience will be able to:

Identify important social media case law updates

Recognize when liability for a breach of duty would attach

Explain the updates to legislation involving the electronic communications paradigm

38


2:15p-3:15p Room: Tilghman Auditorium

Drug-Resistant Mycobacteria: The Current State of

Diagnostics Course # 612-132-14 / 1.0 credit hours

Nicole Parrish, PhD, MHS, D(ABMM) Assistant Professor of Pathology Director of Medical Mycobacteriology, The Johns Hopkins Hospital

Level of Instruction: Intermediate Category: Microbiology Target Audience: All are welcome Description: The talk will focus on the emergence of antibiotic resistance in the mycobacteria, including slow-growing and rapid-growing species as well as M. tuberculosis. Clinical cases will be used to illustrate particular examples. Specific attention will be paid to emerging issues with regard to antibiotic susceptibility testing and detection of resistance. Objectives: At the completion of the presentation, the audience will be able to:

Discuss emerging resistance in mycobacteria

Describe drug susceptibility testing and emerging issues

39


3:30-4:30p Room: Tilghman Auditorium

Pathology’s Role in Patient- and Family-Centered

Care Course # 612-106-14 / 1.0 credit hours

Christine M. Hostetter, MA, MT(ASCP) Education & Staff Development Coordinator, Core and Specialty Laboratories, The Johns Hopkins Hospital

Level of Instruction: Basic Category: General Target Audience: All are welcome Description: Johns Hopkins Medicine’s Strategic Plan includes a patient- and family-centered care priority. This presentation and group discussion will illuminate ways that Pathology is already participating in this strategy and will explore new initiatives to be an integral part of JHM’s aim to “Be the National Leader in the Safety, Science, Teaching and Provision of Patient- and Family-Centered Care.” Objectives: At the completion of the presentation, the audience will be able to:

Summarize the patient- and family-centered care movement throughout the United States and adopted by Johns Hopkins Medicine and pathology professional societies

Recognize, celebrate, and promote everyday patient- and family-centered activities in the Pathology workplace

Plan and initiate new opportunities to strengthen the bond between Pathology employees and patients and their families

40

Thursday, October 2, 2014

7:30a-11:30a: Registration (Turner Concourse) 8:00a-9:00a Room: TBD

Repurposing and Other Thrifty Shades of Green Course # 612-104-14 / 1.0 credit hours

Karen Wittler, HT(ASCP) Histology Tech II, Anatomic Pathology, The Johns Hopkins Hospital

Level of Instruction: Basic Category: General and Safety Target Audience: All are welcome Description: The journey continues…. A clever repurposing project was largely responsible for the Histology Lab’s attainment of The Johns Hopkins Hospital’s 2013 Sustainability Award for “The Greenest Department.” We will retrace our path from NSH workshop, “Green Histology,” to the award, with an emphasis on taking responsibility for more difficult challenges that we face. We must reduce exposure to hazardous materials to ensure a safer work environment, which is a darker shade of Going Green. The 2014 JHH Greenest Department Contest is underway and the entries are remarkable! Prepare to share in the cost-saving and environmentally-friendly measures taken by our rivals, but Histology’s entry will be Top Secret until September. Objectives: At the completion of the presentation, the audience will be able to:

Demonstrate how new information can be implemented and have surprising results

Discuss the challenges of getting everyone to “buy in” to a Green Initiative

Utilize JHH resources that are available to assist you in “greening” your workplace

Create a safer work environment by reducing exposure to hazardous materials

41



Best Practices in Phlebotomy (Repeat presentation)


Charles Andrews Jr., PBT (ASCP) PACE Business Analyst, Johns Hopkins Healthcare

Level of Instruction: Basic Category: Phlebotomy Target Audience: Phlebotomists, technologists, leads, supervisors, managers, nurses, physicians

Description: Phlebotomists are the face of the clinical laboratory because they are the primary interaction patients have with their laboratory results. Phlebotomy skill is not only drawing blood for testing, but involves interacting and answering patient questions, and ensuring that the right specimen from the right patient is drawn at the right time. Objectives: At the completion of the presentation, the audience will be able to:

Identify the role of the phlebotomist in the process of diagnosis and/or treating patients

Explain the importance of proper patient identification

Prepare to respond to patient questions during phlebotomy

42



Therapeutic Plasma Exchange in Kidney Transplant

Recipients at The Johns Hopkins Hospital Course # 612-121-14 / 1.0 credit hours

Andrea McGonigle, MD Transfusion Medicine Fellow, The Johns Hopkins University School of Medicine

Level of Instruction: Intermediate Category: Immunohematology/Blood Bank Target Audience: Technologists, leads, supervisors, managers, educators, nurses, physicians, physician assistants, transfusionists

Description: Therapeutic plasma exchange (TPE) can reduce high-titer antibodies which are responsible for humoral rejection in kidney and other solid organ transplants. This technique is particularly useful in ABO-mismatched transplantation, where it can be used to lower the peritransplant antibody titer to prevent hyperacute rejection and improve graft survival. TPE also plays a similar role in reducing HLA antibodies prior to and following kidney transplantation. Following transplantation, if antibody titers increase or clinical and histologic signs of humoral rejection arise, TPE can then be used as an effective adjunct therapy. Objectives: At the completion of the presentation, the audience will be able to:

Describe the therapeutic plasma exchange program for ABO-mismatched kidney transplant recipients at JHH

Describe the role of therapeutic plasma exchange in reducing HLA antibodies in kidney transplant recipients at JHH

Describe the use of therapeutic plasma exchange as an adjunct therapy for humoral rejection in kidney transplant

43



Basics of Lean Improvement Explained Course # 612-133-14 / 1.0 credit hours

Richard Hill, CLSBB Senior Quality and Innovation Coach, Johns Hopkins Medicine

Level of Instruction: Basic Category: Quality Assurance Target Audience: All are welcome Description: Lean methodology is used to help health care organizations improve quality and reduce costs. It can be applied to virtually any system where waste exists. Attend this session with a quality/innovations coach from the Armstrong Institute to answer the following questions: What is Lean? What is waste? How does waste impact my life? What can I do about it? Examples of waste present at home and at work will be discussed. Objectives: At the completion of the presentation, the audience will be able to:

Identify the various forms of waste that can be reduced/eliminated

Describe how waste can be seen

Discover and apply simple tools to fix the waste

44


10:30a-11:30a Room: TBD

Diabetes: Testing, Diagnosis, and Management Course # 612-116-14 / 1.0 credit hours

Chris Crutchfield, PhD Clinical Chemistry Fellow, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Clinical Chemistry Target Audience: Technologists, technicians, and all are welcome Description: Diabetes has had a major impact on the American public. Over one million adults are diagnosed annually. These individuals may have heard about diabetes or have a family member with it, but may not understand how to interpret the tests their doctor orders for them, or how the management of their disease impacts their wellbeing. This lecture will give an overview of the development of diabetes, the laboratory tests that are ordered for a patient with diabetes, and how these tests directly inform the management of the disease. Objectives: At the completion of the presentation, the audience will be able to:

Describe the differences between Type I and Type II diabetes

Explain how different lab tests are used for the diagnosis and management of diabetes

Discuss the consequences of untreated diabetes

Review different strategies for improving the outcomes of patients with diabetes

45


10:30a-11:30a Room: TBD

Combatting Negativity in the Workplace Course # 612-134-14 / 1.0 credit hours

Alissa Putman, PhD Director, FASAP, The Johns Hopkins University

Level of Instruction: Basic Category: General Target Audience: All are welcome Description: “Negative attitudes spread to the point where they eventually affect performance and decision-making. That's the bad news. The good news is that enthusiasm and positive attitudes spread just as quickly and affect performance just as much -- in the right direction.” (Dale Carnegie). There are several factors which contribute to negativity, including maladaptive thoughts, increased stress, increased conflict and decreased support. The presence of negativity in the workplace is on the rise and adversely affects work performance, relationships, and ultimately patient care. This workshop will detail factors that contribute to negativity in the workplace, as well as ways to combat them to ensure a more positive work environment. Topics covered will include: identifying and stopping maladaptive thoughts, learning stress management and conflict management techniques, preventing burnout and compassion fatigue, and building resiliency. Objectives: At the completion of the presentation, the audience will be able to:

Identify six factors that contribute to negativity in the workplace

Identify positive actions that can be taken to combat negativity and to help with being more productive at work

Identify and stop maladaptive thought patterns that cause negativity in the workplace

Identify the meaning of stress, burnout and compassion fatigue and learn ways to reduce each

State 10 ways to build resilience

46


Closing Session

11:45a-12:45p Room: Turner Auditorium

Pathology and the Choosing Wisely® Campaign:

Claiming our Role in Guiding Safer and More Cost-

Effective Test Utilization


Genevieve M. Crane, MD, PhD Resident Physician, PGY2, Department of Pathology, The Johns Hopkins University School of Medicine

Level of Instruction: Basic Category: Phlebotomy/Safety Target Audience: All are welcome

Description: The Choosing Wisely® campaign is a nationally-led campaign

initiated by the American Board of Internal Medicine with the goal of promoting conversations between physicians and patients to better utilize limited resources for health care. Over 40 national medical organizations, including the ASCP, have released lists of five things that should be questioned and may be overused or inappropriately used. At Johns Hopkins Medicine, the resident-led House Staff Patient Quality Council is spearheading an initiative based on this campaign to streamline test utilization to improve both quality and effectiveness of patient care while reducing costs within the system. Pathology should play a key role both in the optimization of tests and in the education of both physicians and patients on when tests are best indicated. Objectives: At the completion of the presentation, the audience will be able to:

List the goals of the nationwide Choosing Wisely® Campaign

Explain the importance of improving physician and patient understanding of medical tests and their efficacy

Identify areas of test overuse that may benefit from closer analysis of potential benefit in specific clinical contexts

Evaluate the evidence demonstrating clinical utility, safety and cost- effectiveness of tests to order them more wisely

Advise patients who may want (or not want) a test based on expectations outside of evidence-based criteria

47

Second Annual Pathology

Educational Symposium Schedule at a Glance

Key:

General Chemistry Computer

Surgical Pathology Hematology Molecular

Blood Bank Microbiology Quality Assurance

Cytology Immunology Phlebotomy

Pathology Symposium Committee Chair: Barbara Parsons & Lorraine Blagg

Barbara Detrick Mayer Rubin Christine Hostetter Meredith Hurston Cynthia Jordan Nancy Nath Debbie Williams Paula Mister Doris Pendergrass Renata Karlos Eun Hee Cho Rosemary Hines Eunhee Rim Sandra Thacker Jo Shim Suzy Nicol Karen Bordenet Tammy Heacock Kurt Michael Vanessa Rodas-Eral Marian Turpin

48

Lun

ch

(We

st Ro

om

)

Ro

om

#2

Ro

om

#1

Hu

rd H

all

Re

gistra

tion

(Low

er Tu

rne

r Co

nc

ou

rse)

Mo

nd

ay

Se

pte

mb

er 2

9, 2

01

4

Pa

tho

log

y

Gra

nd

Ro

un

ds

8:3

0 A

M

Re

gistra

tion

9a

-3:3

0p

Ce

liac

Dise

ase

an

d

Glu

ten

-

rela

ted

diso

rde

rs

Jo

urn

ey

of a

Bre

ast

Bio

psy

Pa

rt 1

10

:00

AM

Histo

ry o

f

Jo

hn

s

Ho

pk

ins

Pa

tho

log

y

Jo

urn

ey

of a

Bre

ast

Bio

psy

Pa

rt 2

11

:15

AM

Lun

ch

12

:15

PM

HPV

-Re

late

d

He

ad

& N

ec

k

squ

am

ou

s

Ce

ll

Ca

rcin

om

a

Blo

od

Gro

up

Fa

mily

Fe

ud

1:0

0 P

M

Lab

ora

tory

in D

iag

no

sis

of H

um

an

Alle

rgic

Dise

ase

Tissue

Do

na

tion

for

Tran

spla

nta

tion

2:1

5 P

M

Ste

m C

ell

Pro

du

cts:

Wh

at’s in

the

Ba

g?

3:3

0 P

M

Se

co

nd

An

nu

al P

ath

olo

gy

Ed

uc

atio

na

l Sy

mp

osiu

m

Sc

he

du

le a

t a G

lan

ce

Se

co

nd

An

nu

al P

ath

olo

gy

Ed

uc

atio

na

l Sy

mp

osiu

m

Sc

he

du

le a

t a G

lan

ce

49

Lun

ch

(We

st Ro

om

)

Ro

om

#3

Ro

om

#2

Ro

om

#1

Re

gistra

tion

(Lo

we

r Turn

er C

on

co

urse

)

Tue

sda

y

Se

pte

mb

er 3

0, 2

01

4

Re

gistra

tion

8a

-3:3

0p

8:0

0

AM

The

Art o

f Qu

ality

(40

pe

rson

min

imu

m)

2 h

rs

Em

erg

ing

an

d R

e-

em

erg

ing

Vira

l

Infe

ctio

ns

Ne

xt

Ge

ne

ratio

n o

f

Ca

nc

er

Dia

gn

ostic

s:

Clin

ica

l

Pro

teo

mic

s

8:3

0 A

M

TB Te

sting

in

Inte

rna

tion

al

Lab

ora

torie

s

Re

spo

nse

to S

ho

ote

r

Ev

en

t

9:4

5 A

M

No

t Yo

ur

Typ

ica

l Blo

od

Ba

nk

Ca

se

Stu

die

s

We

ird

Mic

ro, P

art

De

ux

Pre

ve

nt

Disru

ptiv

e

Be

ha

vio

rs

from

Esc

ala

ting

at W

ork

11

:00

AM

Lun

ch

12

:00

PM

Clin

ica

l Lab

ora

tory

in S

ub

-

Sa

ha

ran

Afric

a

2 h

rs

Of P

lag

ue

an

d

Pe

stilen

ce

Leg

al H

igh

:

A P

ac

ke

t

an

d a

Pa

tien

t

1:0

0 P

M

Mic

rob

iolo

gy

Of F

oo

d

Dia

gn

osis &

Trea

tme

nt o

f

TTP

2:1

5 P

M

Sa

fety

of

Tod

ay

’s

Pla

sma

De

rive

d

Pro

du

cts

3:3

0 P

M

Se

co

nd

An

nu

al P

ath

olo

gy

Ed

uc

atio

na

l Sy

mp

osiu

m

Sc

he

du

le a

t a G

lan

ce

50

Lun

ch

(We

st Ro

om

)

Ro

om

#3

Ro

om

#2

Ro

om

#1

Re

gistra

tion

(Lo

we

r Turn

er C

on

co

urse

)

We

dn

esd

ay

Oc

tob

er 1

, 20

14

Re

gistra

tion

8a

-3:3

0p

8:0

0

AM

The

Art o

f Qu

ality

Co

ntro

l

(40

pe

rson

min

imu

m)

2 h

rs

Be

st

Pra

ctic

es in

Ph

leb

oto

my

He

ma

tolo

gy

Ho

dg

eP

od

ge

8:3

0 A

M

Ro

le o

f Fin

e

Ne

ed

le

Asp

iratio

n in

He

ad

& N

ec

k

Ma

ss Lesio

ns

Me

etin

g

Me

an

ing

ful U

se

Sta

ge

2: A

Fo

cu

s from

the

Lab

ora

tory

9:4

5 A

M

An

timic

rob

ial

Su

sce

ptib

ility

Testin

g:

Co

mm

on

Bra

in a

nd

Ey

e

Sp

ec

ime

ns

& D

isea

se

Kn

ow

Yo

ur

Tea

m

11

:00

AM

Lun

ch

12

:00

PM

Insp

ec

tion

Re

ad

ine

ss

Ne

xt

Ge

ne

ratio

n

Se

qu

en

cin

g

Inn

ov

atio

n:

Thin

kin

g

Ou

tside

The

Bo

x

(Limit 2

5)

1:0

0 P

M

Dru

g

Re

sistan

t

Mycobacte

ria

So

cia

l Me

dia

Liab

ility fo

r

He

alth

Ca

re

Pra

ctitio

ne

rs

2:1

5 P

M

Pa

tho

log

y’s

Ro

le in

Pa

tien

t &

Fa

mily

Ce

nte

red

Ca

re

3:3

0 P

M

Se

co

nd

An

nu

al P

ath

olo

gy

Ed

uc

atio

na

l Sy

mp

osiu

m

Sc

he

du

le a

t a G

lan

ce

51

Ro

om

#2

Ro

om

#1

Re

gistra

tion

(Low

er Tu

rne

r Co

nc

ou

rse)

Thu

rsda

y

Oc

tob

er 2

, 20

14

Re

gistra

tion

7:3

0a

-11:4

5p

7:3

0

AM

Be

st Pra

ctic

es in

Ph

leb

oto

my

Re

pu

rpo

sing

an

d

Oth

er Th

rifty

Sh

ad

es o

f Gre

en

8:0

0 A

M

The

rap

eu

tic

Pla

sma

Ex

ch

an

ge

in K

idn

ey

Tran

spla

nt

Re

cip

ien

ts

Ba

sics o

f LEA

N

imp

rov

em

en

t

ex

pla

ine

d

9:1

5 A

M

Co

mb

attin

g

Ne

ga

tivity

in th

e

Wo

rkp

lac

e

Dia

be

tes: Te

sting

,

Dia

gn

osis, &

Ma

na

ge

me

nt

10

:30

AM

Pa

tho

log

y a

nd

the

Ch

oo

sing

Wise

ly®

Ca

mp

aig

n

11

:45

PM

Se

co

nd

An

nu

al P

ath

olo

gy

Ed

uc

atio

na

l Sy

mp

osiu

m

Sc

he

du

le a

t a G

lan

ce

Se

co

nd

An

nu

al P

ath

olo

gy

Ed

uc

atio

na

l Sy

mp

osiu

m

Sc

he

du

le a

t a G

lan

ce

52

REGISTRATION

Name: _____________________________ Badge #:___________________ Email: ________________________________________________________ JHM Entity: ________________ Division: ___________________________ Supervisor/Manager: ___________________________________________

Selection for the Sessions: Employee: This is a preliminary schedule and is subject to change. To aid us in planning and assigning rooms for each talk, please mark the sessions that you would like to attend. Registration deadline is Thursday, September 11, 2014. Fill out and submit to your Supervisor for approval. Are you interested in Volunteering for this event? Yes No Please visit to select volunteer opportunity : http://vols.pt/mhpovk Supervisor: After approving registrations for your staff, each employee will need to be registered no later than Tuesday, September 16, 2014, at https://www.surveymonkey.com/s/registration2ndpathologysymposium. MONDAY, SEPTEMBER 29, 2014 Time Course

10:00-11:00a 612-141-14, Celiac Disease & Gluten-Related Disorders 10:00-11:00a 612-108-14, Journey of a Breast Biopsy: Part 1 11:15-12:15p 612-109-14, Journey of a Breast Biopsy: Part 2 11:15-12:15p 612-101-14, Pathology at Johns Hopkins: A History 1:00-2:00p 612-102-14, Blood Group Family Feud 1:00-2:00p 612-127-14, HPV-Related Head and Neck Squamous Cell Carcinoma 2:15-3:15p 612-120-14, Laboratory Dx of Human Allergic Disease 2:15-3:15p 612-124-14, Tissue Donation for Transplantation 3:30-4:30p 612-135-14, Stem Cell Products: What’s in the Bag? TUESDAY, SEPTEMBER 30, 2014 Time Course

8:30-9:30a 612-114-14, Next Generation of Cancer Diagnostics: Clinical Proteomics? 8:30-9:30a 612-129-14, Emerging and Re-emerging Viral Infections 8:30-10:45a 612-118-14, Art of Quality Control 9:45-10:45a 612-117-14, TB Testing in International Laboratories 9:45-10:45a 612-138-14, JHH Response to Shooter Event

http://vols.pt/mhpovk

https://www.surveymonkey.com/s/registration2ndpathologysymposium

53

REGISTRATION (continued) TUESDAY, SEPTEMBER 30, 2014 (continued) Time Course

11:00-12:00p 612-103-14, Weird Micro, Part Deux 11:00-12:00p 612-125-14, Preventing Disruptive Behavior 11:00-12:00p 612-105-14, Not Your Typical Blood Bank Case Studies 1:00-2:00p 612-122-14, Legal Highs: A Packet and a Patient 1:00-2:00p 612-130-14, Of Plague and Pestilence 1:00 – 3:15p 612-110-14, Clinical Laboratory in Sub-Saharan Africa 2:15-3:15p 612-136-14, Microbiology of Food 2:15-3:15p 612-137-14, Diagnosis & Treatment of TTP 3:30-4:30p 612-139-14, Safety of Today’s Plasma Derived Products

WEDNESDAY, OCTOBER 1, 2014 Time Course

8:30-9:30a 612-119-14, Hematology Hodgepodge 8:30-9:30a 612-142-14, Best Practices in Phlebotomy 8:30-10:45a 612-118-14, Art of Quality Control 9:45-10:45a 612-107-14, Meeting Meaningful Use Stage 2 9:45-10:45a 612-126-14, Fine Needle Aspiration of Head & Neck 11:00-12:00p 612-140-14, Know Your Team 11:00-12:00p 612-115-14, Common Brain & Eye Specimens & Disease 11:00-12:00p 612-131-14, Antimicrobial Susceptibility Testing 1:00-2:00p 612-113-14, Next Generation Sequencing 1:00-2:00p 612-128-14, Inspection Readiness 1:00-2:00p 612-123-14, Innovation: Thinking Outside the Box(Limited) 2:15-3:15p 612-112-14, Social Media Liability for Health Care 2:15-3:15p 612-132-14, Drug-Resistant Mycobacteria 3:30-4:30p 612-106-14, Pathology’s Role in Patient- and Family- Centered Care THURSDAY, OCTOBER 2, 2014 Time Course

8:00-9:00a 612-104-14, Repurposing & Thrifty Shades of Green 8:00-9:00a 612-142-14, Best Practices in Phlebotomy 9:15-10:15a 612-121-14, Therapeutic Plasma Exchange in Kidney Transplant Recipients 9:15-10:15a 612-133-14, Basics of Lean Improvement Explained 10:30-11:30a 612-116-14, Diabetes: Testing, Dx, & Management 10:30-11:30a 612-134-14, Combatting Negativity in Workplace 11:45-12:45p 612-111-14, Pathology & Choosing Wisely® Campaign

second annual pathology educational...

Documents